Published in Eur J Pharm Biopharm on March 01, 2001
Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells. Adv Drug Deliv Rev (2012) 1.25
Oral insulin and buccal insulin: a critical reappraisal. J Diabetes Sci Technol (2009) 1.17
Mucoadhesive drug delivery system: An overview. J Adv Pharm Technol Res (2010) 1.05
Physicochemical and formulation developability assessment for therapeutic peptide delivery--a primer. AAPS J (2014) 0.96
A review on bioadhesive buccal drug delivery systems: current status of formulation and evaluation methods. Daru (2011) 0.92
Delivery of optical contrast agents using Triton-X100, part 2: enhanced mucosal permeation for the detection of cancer biomarkers. J Biomed Opt (2009) 0.83
Efficient mucosal delivery of optical contrast agents using imidazole-modified chitosan. J Biomed Opt (2010) 0.83
In vitro characterization of chitosan gels for buccal delivery of celecoxib: influence of a penetration enhancer. AAPS PharmSciTech (2011) 0.82
Formulation and in vitro evaluation of xanthan gum or carbopol 934-based mucoadhesive patches, loaded with nicotine. AAPS PharmSciTech (2010) 0.78
Transbuccal delivery of 5-aza-2 -deoxycytidine: effects of drug concentration, buffer solution, and bile salts on permeation. AAPS PharmSciTech (2007) 0.76
The quorum sensing peptides PhrG, CSP and EDF promote angiogenesis and invasion of breast cancer cells in vitro. PLoS One (2015) 0.76
Emerging Trends in Noninvasive Insulin Delivery. J Pharm (Cairo) (2014) 0.75
Pre-formulation and systematic evaluation of amino acid assisted permeability of insulin across in vitro buccal cell layers. Sci Rep (2016) 0.75
Intestinal transepithelial permeability of oxytocin into the blood is dependent on the receptor for advanced glycation end products in mice. Sci Rep (2017) 0.75
Stable cosmid vectors that enable the introduction of cloned fragments into a wide range of gram-negative bacteria. Gene (1983) 2.55
Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med (1994) 2.14
Inositol Metabolism in Plants. V. Conversion of Myo-inositol to Uronic Acid and Pentose Units of Acidic Polysaccharides in Root-tips of Zea mays. Plant Physiol (1968) 2.11
Chitosan: a unique polysaccharide for drug delivery. Drug Dev Ind Pharm (1998) 2.09
Heterodimerization of the IL-2 receptor beta- and gamma-chain cytoplasmic domains is required for signalling. Nature (1994) 1.93
Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations. J Pharm Pharm Sci (2006) 1.75
Close phenotypic and functional similarities between human and murine alphabeta T cells expressing invariant TCR alpha-chains. J Immunol (1997) 1.63
Transport of pefloxacin across the bacterial cytoplasmic membrane in quinolone-susceptible Staphylococcus aureus. Antimicrob Agents Chemother (1992) 1.62
Skin penetration and distribution of polymeric nanoparticles. J Control Release (2004) 1.48
Mechanisms of potassium chloride release from compressed, hydrophilic, polymeric matrices: effect of entrapped air. J Pharm Sci (1983) 1.38
Translationally controlled tumor protein: a protein identified in several nontumoral cells including erythrocytes. Electrophoresis (1997) 1.36
Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts. N Engl J Med (1990) 1.35
Passive skin penetration enhancement and its quantification in vitro. Eur J Pharm Biopharm (2001) 1.34
The expression and impact of antifungal grooming in ants. J Evol Biol (2011) 1.23
Natural splicing of exon 2 of human interleukin-15 receptor alpha-chain mRNA results in a shortened form with a distinct pattern of expression. J Biol Chem (1999) 1.17
Molecular properties of the action potential Na+ ionophore in neuroblastoma cells. Interactions with neurotoxins. J Biol Chem (1978) 1.13
Lectins as markers of human epidermal cell differentiation. Differentiation (1982) 1.12
Identification of a tetrodotoxin-sensitive Na+ channel in a variety in fibroblast lines. Nature (1980) 1.12
Antirespiratory and antiproliferative activity of anthralin in cultured human keratinocytes. J Invest Dermatol (1985) 1.11
Iontophoresis: electrorepulsion and electroosmosis. J Control Release (2000) 1.11
The sodium channel in non-impulsive cells. Interaction with specific neurotoxins. Biochim Biophys Acta (1979) 1.09
Polymerase chain reaction-based gene disruption in Trypanosoma brucei. Mol Biochem Parasitol (1997) 1.08
Comparative pharmacokinetic study of a floating multiple-unit capsule, a high-density multiple-unit capsule and an immediate-release tablet containing 25 mg atenolol. Pharm Acta Helv (1998) 1.06
Effect of controlled laser microporation on drug transport kinetics into and across the skin. J Control Release (2010) 1.06
Stimulation of leukemia inhibitory factor receptor degradation by extracellular signal-regulated kinase. J Biol Chem (2000) 1.05
Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention. Int J Pharm (1999) 1.02
Activation of the signal transducer gp130 by interleukin-11 and interleukin-6 is mediated by similar molecular interactions. Biochem J (1998) 1.02
Visualization of skin penetration using confocal laser scanning microscopy. Eur J Pharm Biopharm (2004) 1.01
Interaction of pyrethroids with the Na+ channel in mammalian neuronal cells in culture. Biochim Biophys Acta (1980) 1.00
D-Glucose transport in Trypanosoma brucei. D-Glucose transport is the rate-limiting step of its metabolism. Eur J Biochem (1978) 1.00
T lymphocyte cloning from rejected human kidney allografts. Growth frequency and functional/phenotypic analysis. J Clin Invest (1986) 0.98
Biophysical study of porcine ear skin in vitro and its comparison to human skin in vivo. J Pharm Sci (2002) 0.97
The mannose 6-phosphate/insulin-like growth factor II receptor is a nanomolar affinity receptor for glycosylated human leukemia inhibitory factor. J Biol Chem (1998) 0.96
In vivo assessment of enhanced topical delivery of terbinafine to human stratum corneum. J Control Release (2001) 0.96
Regulation of interleukin 2 receptor expression on a human cytotoxic T lymphocyte clone, synergism between alloantigenic stimulation and interleukin 2. J Immunol (1986) 0.95
Contributions of electromigration and electroosmosis to iontophoretic drug delivery. Pharm Res (2001) 0.95
Myo-inositol transport in Aerobacter aerogenes. Biochim Biophys Acta (1972) 0.95
Prevention of rejection of kidney transplants by monoclonal antibody directed against interleukin 2. Lancet (1987) 0.95
Transdermal therapy and diagnosis by iontophoresis. Trends Biotechnol (1997) 0.95
Characterization of the permeability barrier of human skin in vivo. Proc Natl Acad Sci U S A (1997) 0.95
Purification and characterization of a long chain, fatty-acid-binding protein supplying the mitochondrial beta-oxidative system in the heart. Biochim Biophys Acta (1978) 0.93
Buoyancy and drug release patterns of floating minitablets containing piretanide and atenolol as model drugs. Pharm Dev Technol (1998) 0.93
The effect of current on skin barrier function in vivo: recovery kinetics post-iontophoresis. Pharm Res (1997) 0.93
Stimulus-response coupling in insulin-secreting HIT cells. Effects of secretagogues on cytosolic Ca2+, diacylglycerol, and protein kinase C activity. J Biol Chem (1990) 0.93
Methionyl-tRNA synthetase from Escherichia coli: active stoichiometry and stopped-flow analysis of methionyl adenylate formaiton. Biochemistry (1976) 0.93
Transport of cyclitols by a proton symport in Klebsiella aerogenes. Eur J Biochem (1977) 0.92
Effect of ethanol and isopropyl myristate on the availability of topical terbinafine in human stratum corneum, in vivo. Int J Pharm (2001) 0.92
Monoolein: a review of the pharmaceutical applications. Drug Dev Ind Pharm (2000) 0.92
Myo-Inositol transport in Klebsiella aerogenes. scyllo-Inositol, a non-metabolizable substrate for the study of the myo-inositol transport system. Eur J Biochem (1977) 0.91
Lack of intermediate-affinity interleukin-2 receptor in mice leads to dependence on interleukin-2 receptor alpha, beta and gamma chain expression for T cell growth. Eur J Immunol (1996) 0.90
Myo-inositol transport system in Pseudomonas putida. J Bacteriol (1977) 0.90
Supersaturation: enhancement of skin penetration and permeation of a lipophilic drug. Pharm Res (2001) 0.90
Purification and properties of the myo-inositol-binding protein from a Pseudomonas sp. J Bacteriol (1984) 0.90
[Biochemical proterties of Schizosaccharomyces plmbe depending on culture conditions and on the action of inhibitors. II. Composition of the cell walls]. Biochim Biophys Acta (1969) 0.89
Kistrin, an integrin antagonist, blocks endocytosis of fibrinogen into guinea pig megakaryocyte and platelet alpha-granules. J Clin Invest (1993) 0.89
Stereospecificity of the myo-inositol transport system of Aerobacter aerogenes and sensitivity towards sulfhydryl reagents. Experientia (1974) 0.88
Interrelation between transfer RNA and amino-acid-activating sites of methionyl transfer RNA synthetase from Escherichia coli. Eur J Biochem (1977) 0.88
Production and characterization of monoclonal antibodies against the leukemia inhibitory factor low affinity receptor, gp190. J Immunol Methods (1997) 0.88
Mannose 6-Phosphate/Insulin-like growth factor II receptor mediates internalization and degradation of leukemia inhibitory factor but not signal transduction. J Biol Chem (1999) 0.88
Secretion of disulfide-linked human T-cell receptor gamma delta heterodimers. J Biol Chem (1993) 0.88
Follow-up of soluble interleukin-2 receptor levels after thymectomy in patients with myasthenia gravis. Clin Immunol Immunopathol (1992) 0.88
Anti-interleukin 2 receptor monoclonal antibodies. Respective role of epitope mapping and monoclonal antibody-receptor interactions in their antagonist effects on interleukin 2-dependent T cell growth. Eur J Immunol (1986) 0.87
Anti-interleukin 2 receptor monoclonal antibody in the treatment of ongoing acute rejection episodes of human kidney graft--a pilot study. Transplantation (1989) 0.87
Skin permeability enhancement by low frequency sonophoresis: lipid extraction and transport pathways. J Pharm Sci (2003) 0.87
Identification of the domain in the human interleukin-11 receptor that mediates ligand binding. J Mol Biol (2001) 0.86
Human growth hormone: new delivery systems, alternative routes of administration, and their pharmacological relevance. Eur J Pharm Biopharm (2011) 0.86
Enhanced skin permeation of a lipophilic drug using supersaturated formulations. J Control Release (2001) 0.86
Loss of oncostatin M receptor beta in metastatic melanoma cells. Oncogene (2006) 0.86
Effect of anti-LFA1 (CD11a) monoclonal antibodies in acute rejection in human kidney transplantation. Transplantation (1991) 0.86
Optimizing iontophoretic drug delivery: identification and distribution of the charge-carrying species. Pharm Res (2001) 0.86
In vitro study of percutaneous absorption, cutaneous bioavailability and bioequivalence of zinc and copper from five topical formulations. Skin Pharmacol (1996) 0.85
[Inositol transport in Schizosaccharomyces pombe]. Biochim Biophys Acta (1970) 0.85
Piroxicam delivery into human stratum corneum in vivo: iontophoresis versus passive diffusion. J Control Release (2001) 0.85
Electrorepulsion versus electroosmosis: effect of pH on the iontophoretic flux of 5-fluorouracil. Pharm Res (1999) 0.84
Stratum corneum thickness and apparent water diffusivity: facile and noninvasive quantitation in vivo. Pharm Res (1998) 0.84
Chromosome mapping and expression of the human interleukin-13 receptor. Genomics (1997) 0.84
Production of human interleukin for DA cells (HILDA)/leukemia inhibitory factor (LIF) by activated monocytes. Cell Immunol (1990) 0.84
A fusion protein of interleukin-11 and soluble interleukin-11 receptor acts as a superagonist on cells expressing gp130. FEBS Lett (1999) 0.84
[Formulation of sustained-release tablets. II. Hydrophilic matrices]. Pharm Acta Helv (1980) 0.84
Antibodies directed at mouse IL-2-R alpha and beta chains act in synergy to abolish T-cell proliferation in vitro and delayed type hypersensitivity reaction in vivo. Transpl Int (1996) 0.84
Non-invasive assessment of the effects of iontophoresis on human skin in-vivo. J Pharm Pharmacol (2001) 0.84
Negative cross-talk between interleukin-3 and interleukin-11 is mediated by suppressor of cytokine signalling-3 (SOCS-3). Biochem J (2001) 0.84
Molecular cloning of two isoforms of a receptor for the human hematopoietic cytokine interleukin-11. Blood (1995) 0.84
Assessment and prediction of the cutaneous bioavailability of topical terbinafine, in vivo, in man. Pharm Res (2001) 0.84
Prodrugs for the improvement of drug absorption via different routes of administration. Eur J Drug Metab Pharmacokinet (1990) 0.84
Relationship between responsiveness of cancer cells to Oncostatin M and/or IL-6 and survival of stage III melanoma patients treated with tumour-infiltrating lymphocytes. J Pathol (2008) 0.83
Interleukin-15 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome). Br J Dermatol (2001) 0.83
Transport of gamma-butyrobetaine in an Agrobacterium species isolated from soil. J Bacteriol (1986) 0.83
Reconstitution of two isoforms of the human interleukin-11 receptor and comparison of their functional properties. FEBS Lett (1997) 0.83
Biochemical characterization and purification of HILDA, a human lymphokine active on eosinophils and bone marrow cells. Blood (1988) 0.83
Constitutive production of human interleukin for DA cells/leukemia inhibitory factor by human tumor cell lines derived from various tissues. J Immunol (1990) 0.83
Using controlled laser-microporation to increase transdermal delivery of prednisone. J Control Release (2010) 0.83
Detection of ligand-protein binding by direct electrophoresis of the complex. J Chromatogr (1988) 0.82
Prophylactic use of a monoclonal antibody (33B3.1) directed against interleukin 2 receptor following human renal transplantation. Am J Kidney Dis (1988) 0.82
Cloning of genes involved in myo-inositol transport in a Pseudomonas sp. J Bacteriol (1985) 0.82
Definition of receptor binding sites on human interleukin-11 by molecular modeling-guided mutagenesis. Eur J Biochem (1999) 0.82
Iontophoretic transport across the skin. Skin Pharmacol Appl Skin Physiol (2001) 0.82
Human fusion proteins between interleukin 2 and IgM heavy chain are cytotoxic for cells expressing the interleukin 2 receptor. Proc Natl Acad Sci U S A (1992) 0.82